Bemarituzumab Improves OS, Not PFS, in Gastric and GEJ Cancer
Adding bemarituzumab to chemotherapy improved overall survival in FGFR2b-expressing gastric or gastroesophageal junction cancer.
Gastric Cancer
Diverticular Disease Associated With Increased Risk of Multiple Cancers
Patients with diverticular disease had an increased risk of lung, prostate, breast, hematologic, colorectal, gastric, liver, and pancreatic cancers.
Several Factors May Predict Risk of ILD/Pneumonitis After Trastuzumab Deruxtecan
The risk of ILD/pneumonitis was associated with patient age, time since cancer diagnosis, dose of trastuzumab deruxtecan, and other factors.
Laparoscopic Surgery Noninferior for Gastric Cancer at Five Years
At 5 years, OS and RFS rates were similar with laparoscopic surgery and open distal gastrectomy.
Significant County-Level Variability Seen With Gastrointestinal Cancers
Counties in the Southeastern United States primarily accounted for the highest 5% of mortality rates for gastric, pancreatic, and colorectal cancer.
FOLFOX, Nivolumab, Trastuzumab Fares Best in ERBB2-Positive Gastric Cancer
A chemotherapy-containing regimen appears more effective than a chemotherapy-free regimen as first-line therapy for ERBB2-positive gastric cancer.
Eradication of H Pylori Infection Reduces Risk for Gastric Cancer
A team of researchers investigated the long-term effects of eliminating H pylori infection in patients at high risk for gastric cancer.
BRCA1/2 Variants Associated With More Cancers Than Previously Thought
Researchers identified associations between pathogenic variants in BRCA1/2 and 7 cancers.
LNR Tied to Outcome of Adjuvant Chemo in Locally Advanced Gastric Cancer
Patients with lymph node ratios of 9% or higher had better overall survival when they received adjuvant chemotherapy.
Can Aspirin Prevent Gastric Cancer?
New research suggests aspirin may lower the risk for gastric adenocarcinoma in women but not in men.
- Loading...
Loading...
Next post in Gastrointestinal Cancers
Loading... 
Loading...